L-CARNITINE GCCARTIN inj.

GCCARTIN inj. L-Carnitine

Characteristics:   

Brown ampoule injection that contains colorless to pale-yellow liquid.

Full Ingredient:    

Active ingredient in 1mL: 0.2g of L-carnitine

Efficacy/Effect:    

1) Primary and secondary carnitine deficiency

2) Myocardial metabolic disorders due to ischemic heart disease: angina pectoris, acute myocardial infarction

3) Treatment of carnitine deficiency in end-stage renal disease patients undergoing hemodialysis

Usage/Dosage:

1) Primary and secondary carnitine deficiency

Myocardial metabolic disorders due to ischemic heart disease: angina pectoris, acute myocardial infarction

Adults: Intramuscular injection or IV drip of 2~3g L-carnitine per day, divided into 2 or 3 doses.

Increase or decrease the administered amount according to age and symptoms.

2) Treatment of carnitine deficiency in end-stage renal disease patients undergoing hemodialysis

Initially, 10-20mg/kg is administered intravenously over a 2?3-minute period at the end of each hemodialysis.

However, the dosage can be adjusted in accordance with the plasma L-carnitine level before hemodialysis.

Storage:        

Store in an opaque sealed container at room temperature (1~30℃)

Packaging Unit      

5ml * 10 Ampoule injection